Extens, the dedicated European software investor for healthcare, continues to expand by promoting Charles Bourgain and Morgane Decultieux to the newly created role of Executive Director.
Charles Bourgain has been a valuable member of the investment team since 2022, significantly contributing to both the origination and execution of new investments, including the carve-out of Val Solutions, a leading provider of digital solutions in occupational health and safety, marking Extens first investment in this segment. Most recently, Charles played a key role in the successful sales of Must and Teranga to Orisha, an international software publisher backed by Francisco Partners and TA Associates.
Morgane Decultieux, a Doctor in Pharmacy (PharmD), has been an essential part of the investment team since 2021. She has also worked on new investments, particularly expanding the firm’s deal coverage across Europe. Most recently, Morgane led the carve-out of Medicore, a provider of a unique solution for mental health and youth care facilities, marking Extens' first investment outside of France. Prior to joining Extens, she worked with Mérieux Equity Partners and IQVIA.
This newly implemented structure aims to enhance Extens' expertise across both investment strategy and operational capabilities. The firm also plans to bolster its operating team by adding a senior resource to further support its portfolio companies.